{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:48:19Z","timestamp":1761709699117},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T00:00:00Z","timestamp":1592611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Our aim was to investigate the frequency of steatohepatitic morphology in hepatocellular adenoma (HCA) and correlate with its clinical parameters and risk factors underlying nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We examined a series of 41 liver resection specimens diagnosed with HCA for steatohepatitic changes. Background nonneoplastic liver was also evaluated. Clinical records were reviewed for risk factors of NAFLD\/NASH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Six steatohepatitic HCAs (SH-HCAs) were identified, with an overall prevalence of six (14.6%) of 41, of which three were HNF1\u03b1 inactivated and three were inflammatory, but none were \u03b2-catenin mutated. Five of the six patients with SH-HCA had at least one known risk factor for NAFLD\/NASH, including obesity (n = 4; 66.7%), diabetes (n = 5; 83.3%), hypertension (n = 3; 50%), and dyslipidemia (n = 1; 16.7%). Compared with the patients without SH-HCA, the patients with SH-HCA had a higher frequency of type 2 diabetes, obesity, and hypertension. Of the six SH-HCAs, background nonneoplastic liver showed significant steatosis in three (50%) cases and steatohepatitic changes in one (16.7%) case.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Approximately 15% of HCAs in our series demonstrated steatohepatitic changes. Lack of such morphology in \u03b2-catenin\u2013mutated subtype suggests reassurance in this morphologic variant of HCA.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ajcp\/aqaa075","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T19:09:58Z","timestamp":1587582598000},"page":"525-532","source":"Crossref","is-referenced-by-count":7,"title":["Steatohepatitis-Like Changes in Hepatocellular Adenoma"],"prefix":"10.1093","volume":"154","author":[{"given":"Yongjun","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Washington School of Medicine, Seattle"},{"name":"Department of Pathology, University of Wisconsin School of Medicine and Public Health, Madison"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoh","family":"Zen","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan"},{"name":"Institute of Liver Studies, King\u2019s College Hospital & King\u2019s College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew M","family":"Yeh","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Washington School of Medicine, Seattle"},{"name":"Department of Medicine, University of Washington School of Medicine, Seattle"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,6,20]]},"reference":[{"key":"2020090815135531800_CIT0001","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.anndiagpath.2018.09.009","article-title":"Nonalcoholic fatty liver disease (NAFLD): diagnosis, pitfalls, and staging","volume":"37","author":"Koch","year":"2018","journal-title":"Ann Diagn Pathol."},{"key":"2020090815135531800_CIT0002","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.humpath.2011.07.005","article-title":"The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis","volume":"43","author":"Salomao","year":"2012","journal-title":"Hum Pathol."},{"key":"2020090815135531800_CIT0003","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/PAS.0b013e3181f31caa","article-title":"Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD\/NASH","volume":"34","author":"Salomao","year":"2010","journal-title":"Am J Surg Pathol."},{"key":"2020090815135531800_CIT0004","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.humpath.2015.07.018","article-title":"Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study","volume":"46","author":"Yeh","year":"2015","journal-title":"Hum Pathol."},{"key":"2020090815135531800_CIT0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/PAS.0000000000000781","article-title":"Steatohepatitis-like changes in focal nodular hyperplasia, a finding to distinguish from steatohepatitic variant of hepatocellular carcinoma","volume":"41","author":"Deniz","year":"2017","journal-title":"Am J Surg Pathol."},{"key":"2020090815135531800_CIT0006","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/j.gastro.2016.11.042","article-title":"Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation","volume":"152","author":"Nault","year":"2017","journal-title":"Gastroenterology."},{"key":"2020090815135531800_CIT0007","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cld.2009.07.010","article-title":"Fatty liver and liver transplantation","volume":"13","author":"Koehler","year":"2009","journal-title":"Clin Liver Dis."},{"key":"2020090815135531800_CIT0008","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/j.gastro.2014.07.056","article-title":"Pathological features of fatty liver disease","volume":"147","author":"Yeh","year":"2014","journal-title":"Gastroenterology."},{"key":"2020090815135531800_CIT0009","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/hep.29336","article-title":"Argininosuccinate synthase 1 (ASS1): a marker of unclassified hepatocellular adenoma and high bleeding risk","volume":"66","author":"Henriet","year":"2017","journal-title":"Hepatology."},{"key":"2020090815135531800_CIT0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.22995","article-title":"Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience","volume":"50","author":"Bioulac-Sage","year":"2009","journal-title":"Hepatology."},{"key":"2020090815135531800_CIT0011","doi-asserted-by":"crossref","first-page":"14437","DOI":"10.1074\/jbc.M610725200","article-title":"HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation","volume":"282","author":"Rebouissou","year":"2007","journal-title":"J Biol Chem."},{"key":"2020090815135531800_CIT0012","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/modpathol.2013.114","article-title":"Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma","volume":"27","author":"Joseph","year":"2014","journal-title":"Mod Pathol."},{"key":"2020090815135531800_CIT0013","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/PAP.0b013e318234abb4","article-title":"Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques","volume":"18","author":"Shafizadeh","year":"2011","journal-title":"Adv Anat Pathol."},{"key":"2020090815135531800_CIT0014","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.humpath.2016.12.001","article-title":"Distinction between inflammatory hepatocellular adenoma and mass effect on liver sampling","volume":"61","author":"Agostini-Vulaj","year":"2017","journal-title":"Hum Pathol."},{"key":"2020090815135531800_CIT0015","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/his.13016","article-title":"Serum amyloid A immunohistochemical staining patterns in hepatitis","volume":"69","author":"Piotti","year":"2016","journal-title":"Histopathology."},{"key":"2020090815135531800_CIT0016","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/hepr.13203","article-title":"Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: a multicenter study using immunohistochemical analysis of adenoma-related markers","volume":"48","author":"Taniai","year":"2018","journal-title":"Hepatol Res."},{"key":"2020090815135531800_CIT0017","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00428-015-1836-2","article-title":"\u03b2-Catenin alteration is rare in hepatocellular carcinoma with steatohepatitic features: immunohistochemical and mutational study","volume":"467","author":"Ando","year":"2015","journal-title":"Virchows Arch."},{"key":"2020090815135531800_CIT0018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tem.2008.09.002","article-title":"Adipogenesis and WNT signalling","volume":"20","author":"Christodoulides","year":"2009","journal-title":"Trends Endocrinol Metab."},{"key":"2020090815135531800_CIT0019","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10620-013-2873-9","article-title":"Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease","volume":"59","author":"Clarke","year":"2014","journal-title":"Dig Dis Sci."},{"key":"2020090815135531800_CIT0020","doi-asserted-by":"crossref","first-page":"27117","DOI":"10.1016\/S0021-9258(19)61487-0","article-title":"Regulation of the liver fatty acid-binding protein gene by hepatocyte nuclear factor 1alpha (HNF1alpha): alterations in fatty acid homeostasis in HNF1alpha-deficient mice","volume":"275","author":"Akiyama","year":"2000","journal-title":"J Biol Chem."},{"key":"2020090815135531800_CIT0021","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/86871","article-title":"Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism","volume":"27","author":"Shih","year":"2001","journal-title":"Nat Genet."},{"key":"2020090815135531800_CIT0022","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.21068","article-title":"Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC","volume":"43","author":"Zucman-Rossi","year":"2006","journal-title":"Hepatology."},{"key":"2020090815135531800_CIT0023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0031-1272837","article-title":"Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers","volume":"31","author":"Bioulac-Sage","year":"2011","journal-title":"Semin Liver Dis."},{"key":"2020090815135531800_CIT0024","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/MEG.0000000000000930","article-title":"Inflammatory and multiple hepatocellular adenoma are associated with a higher BMI","volume":"29","author":"Br\u00f6ker","year":"2017","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"2020090815135531800_CIT0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0035-1562952","article-title":"The evolving role of nonalcoholic fatty liver disease in hepatic neoplasia: inflammatory hepatocellular adenoma in a man with metabolic syndrome","volume":"35","author":"Lefkowitch","year":"2015","journal-title":"Semin Liver Dis."},{"key":"2020090815135531800_CIT0026","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMra000471","article-title":"Production and actions of estrogens","volume":"346","author":"Gruber","year":"2002","journal-title":"N Engl J Med."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/154\/4\/525\/33726284\/aqaa075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/154\/4\/525\/33726284\/aqaa075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T08:28:47Z","timestamp":1615364927000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/154\/4\/525\/5860232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,20]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,6,20]]},"published-print":{"date-parts":[[2020,9,8]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqaa075","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10,1]]},"published":{"date-parts":[[2020,6,20]]}}}